Patents by Inventor Elizabeth Vadas

Elizabeth Vadas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLUBLE PHARMACEUTICAL COMPOSITIONS COMPRISING SALTS OF DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND
    Publication number: 20240366616
    Abstract: Disclosed are pharmaceutical compositions comprising a salt of a compound having the formula: and one or more excipients, wherein the pharmaceutical composition avoids inducing disproportionation of the salt of the compound.
    Type: Application
    Filed: July 20, 2022
    Publication date: November 7, 2024
    Applicants: Mineralys Therapeutics, Inc., Mitsubishi Tanabe Pharma Corporation
    Inventors: Robert McKean, Roch Thibert, Elizabeth Vadas, Yoshinori Ohashi, Fuminori Ozaki, Hiroki Ohshima, Hiroomi Nagata
  • Oral dosage forms including an antiplatelet agent and an acid inhibitor
    Patent number: 9504678
    Abstract: The present disclosure provides oral dosage forms comprising an antiplatelet agent and an acid inhibitor, as well as methods of treating subjects with an antiplatelet agent and an acid inhibitor.
    Type: Grant
    Filed: April 4, 2007
    Date of Patent: November 29, 2016
    Assignee: KG ACQUISITION LLC
    Inventors: Mark A. Goldsmith, Elizabeth Vadas
  • PHARMACEUTICAL COMPOSITION AND DOSAGE FORMS OF ELINOGREL AND METHODS OF USE THEREOF
    Publication number: 20130165459
    Abstract: The present invention is concerned with a solid delivery form of elinogrel for the treatment of thrombosis which is notable for its multi-pH dissolution, immediate release and improved pharmacokinetic properties and stability in storage. The delivery and dosage form is a solid, oral formulation comprising: a) at least about 15% by weight elinogrel or a pharmaceutically acceptable salt thereof relative to the total weight of the overall pharmaceutical composition, and b) at least one pharmaceutically acceptable carrier. A further aspect of the present invention concerns the preparation and use of such a formulation.
    Type: Application
    Filed: January 12, 2011
    Publication date: June 27, 2013
    Applicants: NORVARTIS PHARMA AG, PORTOLA PHARMACEUTICALS, INC.
    Inventors: Juan Wang, Chandir Ramani, Joe Lambing, Christine Ye, Elizabeth Vadas, Julian Taillemite, Marie-Pierre Filliot, Dieter Becker
  • Oral Pharmaceutical Formulations Containing Non-Steroidal Anti-Inflammatory Drugs and Acid Inhibitors
    Publication number: 20100227854
    Abstract: The present disclosure provides enteric coated capsules and orally dissolving films comprising non-steroidal anti-inflammatory drugs and acid inhibitors, as well as methods of treating treatment humans for pain and/or inflammation while reducing gastrointestinal side effects.
    Type: Application
    Filed: November 11, 2009
    Publication date: September 9, 2010
    Applicant: Horizon Therapeutics, Inc.
    Inventors: James B. Tananbaum, Elizabeth Vadas, Mark A. Goldsmith
  • Oral dosage forms including an antiplatelet agent and an acid inhibitor
    Publication number: 20070243243
    Abstract: The present disclosure provides oral dosage forms comprising an antiplatelet agent and an acid inhibitor, as well as methods of treating subjects with an antiplatelet agent and an acid inhibitor.
    Type: Application
    Filed: April 4, 2007
    Publication date: October 18, 2007
    Applicant: Cogentus Pharmaceuticals, Inc
    Inventors: Mark Goldsmith, Elizabeth Vadas
  • Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
    Publication number: 20070154542
    Abstract: The present disclosure provides enteric coated capsules and orally dissolving films comprising non-steroidal anti-inflammatory drugs and acid inhibitors, as well as methods of treating treatment humans for pain and/or inflammation while reducing gastrointestinal side effects.
    Type: Application
    Filed: December 15, 2006
    Publication date: July 5, 2007
    Applicant: Cogentus Pharmaceuticals, Inc.
    Inventors: James Tananbaum, Elizabeth Vadas, Mark Goldsmith